-
1دورية أكاديمية
المؤلفون: David G. Alleva, Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Stephen A. Shaw, Ari Aminetzah, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
المصدر: npj Vaccines, Vol 9, Iss 1, Pp 1-12 (2024)
مصطلحات موضوعية: Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2059-0105
-
2دورية أكاديمية
المؤلفون: Eline A. Feitsma, Hugo M. Schouw, Milou E. Noltes, Wido Heeman, Wendy Kelder, Gooitzen M. van Dam, Schelto Kruijff
المصدر: Life, Vol 12, Iss 3, p 388 (2022)
مصطلحات موضوعية: optical imaging, fluorescence, thyroidectomy, parathyroid glands, hypoparathyroidism, near-infrared imaging, Science
وصف الملف: electronic resource
-
3Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
المؤلفون: Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma, David G. Alleva, Thomas M. Lancaster, Thillainaygam Sathiyaseelan, Sylaja Murikipudi, Andrea R. Delpero, Melanie M. Scully, Ramya Ragupathy, Sravya Kotha, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao, Shashikant Nagre, Shannon E. Ronca, Freedom M. Green, Ari Aminetzah, Frans Sollie, Schelto Kruijff, Maarten Brom, Gooitzen M. van Dam, Todd C. Zion
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)
المصدر: Vaccine
Vaccine, 40(9), 1253-1260. ELSEVIER SCI LTDمصطلحات موضوعية: Adult, History, COVID-19 Vaccines, Polymers and Plastics, Adolescent, HCS, human convalescent serum, Antibodies, Viral, Industrial and Manufacturing Engineering, Article, Young Adult, Clinical Trials, Phase II as Topic, Immunogenicity, Vaccine, ACE2, angiotensin converting enzyme-2, Humans, Business and International Management, Aged, Fc-fusion, SP/RBD, spike protein receptor binding domain, Infectious disease, SAE, serious adverse event, General Veterinary, General Immunology and Microbiology, Pandemic, SP, Spike Protein, Prophylaxis, SARS-CoV-2, ELISA, Enzyme Linked Immunosorbent Assay, Public Health, Environmental and Occupational Health, COVID-19, Middle Aged, AKS-452, Antibodies, Neutralizing, Coronavirus, Infectious Diseases, Immunoglobulin G, Spike Glycoprotein, Coronavirus, Vaccines, Subunit, Molecular Medicine, Vaccine, AE, adverse event
وصف الملف: application/pdf